BIO-key International, Inc. received Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) for failing to timely file its 2025 Form 10-K, with no immediate impact on stock listing or trading.
Key takeaways
Received Nasdaq notice on April 16, 2026, for non-compliance with Rule 5250(c)(1) due to delayed 10-K filing for year ended December 31, 2025.
Notification has no immediate effect on Nasdaq Capital Market listing or trading of common stock.
Company working with auditors to finalize and file 10-K next week.
Press release issued April 22, 2026, disclosing the Nasdaq notice (Exhibit 99.1, not deemed filed).